The Impact and Safety of GLP‐1 Agents and Breast CancerKayla Parsons, Maryam B. Lustberg, Melissa Taylor et al.|Cancer Medicine|2025Cited by 13
Supplementary Table from Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBCJulia Foldi, Lajos Pusztai, Justin Persico et al.|Unknown|2023Cited by 0
Data from Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBCJulia Foldi, Lajos Pusztai, Adriana Kahn et al.|Unknown|2023Cited by 0